Screening for Advanced Liver Fibrosis Using Non-invasive Tests in Primary Care

Exclusion Criteria

• •Prescription triggering FIB-4 emanate from a hepatogastroenterologist or oncologist
• •Conditions associated with high risk false-positive FIB-4: ASAT or ALAT \> 300 IU/L, platelets \<50 G/L or \>500 G/L.
• •Patient refusing to participate
• •Subjects under guardianship or deprived of liberty